Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, Share & Trends Analysis Report By Service Type, By Synthesis Type, By Therapeutic Category, By Animal Type, By Region, And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within 1 Business Day
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth & Trends
The global veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 10.64 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 6.9% from 2023 to 2030. The key factors driving the industry growth include the growing animal population, rising pet ownership & humanization, high pet expenditure, an increasing number of veterinarians & veterinary visits, and a high prevalence of zoonotic diseases. In addition, the rising demand for pet insurance, strategic initiatives undertaken by key participants, and government initiatives are likely to boost industry growth.Various government policies are affecting the veterinary active pharmaceutical ingredients (API) manufacturing.
For instance, in India, despite a strong base, domestic veterinary pharmaceutical companies have gradually stopped manufacturing veterinary APIs due to low-profit margins. They started importing APIs from other countries, a majority of which are imported from China, which was a cheaper alternative and increased their profit margin on drugs. The Technology Information Forecasting and Assessment Council-an organization under the Department of Science & Technology, India-recommended a few guidelines to address the need for regulating APIs to make India self-reliant and revive its economy post-pandemic. This is important to reduce India’s dependency on China for pharmaceutical goods, including APIs, especially after the tensions between soldiers at the India–China border.
Various guidelines are being issued by government organizations to encourage veterinary services globally, which is anticipated to aid veterinary API manufacturing market growth in the coming years. An increase in the number of government initiatives that help promote animal health is also expected to fuel the overall market growth during the forecast period. The launch of One Health Initiative for enhancing animal healthcare standards has improved growth prospects for the industry. This joint project unified clinical care, disease surveillance, and education & research areas for better control of diseases. The growing need for efficient animal treatment and increasing awareness about pathogenesis & epidemiology have encouraged organizations, such as Companion Animal Adoption Resources and the Federation of European Companion Animal Veterinary Association, to take appropriate measures.
Government and private organizations are constantly updating their guidelines to promote animal health and prevent obesity & other disorders. This is expected to fuel industry growth over the forecast period.The increasing number of oral formulations for various veterinary drugs is boosting the demand for veterinary APIs. These majorly include nonsteroidal anti-inflammatory drugs. Manufacturers are investing in electrochemical synthesis, which helps in accelerating the manufacturing process for APIs. In addition, the introduction of biologically synthesized APIs is a technological innovation that fuels industry growth. Going forward, veterinary biopharmaceuticals produced by rDNA technology will be gaining more significance, as they would be a better choice for managing diseases, such as arthritis, cancer, & diabetes, and autoimmune disorders.
Furthermore, the introduction of High-Potency APIs (HPAPIs), which act on the target cells in a much lower dose as compared to the general APIs, is also expected to offer lucrative growth opportunities in the vet API Manufacturing market. The HPAPIs are creating significant changes in pharmaceutical innovation to deliver new therapeutic medicines.Some of the macroeconomic factors, such as COVID-19, have widely impacted veterinary consumer demand, as human medicines, including antivirals, were in high requirement during the pandemic. According to SeQuent Scientific Ltd., 2021, rising geopolitical tensions amid the Ukraine-Russia conflicts are also expected to create uncertainty in the supply chain, financial stress, & climate-related changes, as well as increase inflation in the near term.
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth & Trends
The global veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 10.64 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 6.9% from 2023 to 2030. The key factors driving the industry growth include the growing animal population, rising pet ownership & humanization, high pet expenditure, an increasing number of veterinarians & veterinary visits, and a high prevalence of zoonotic diseases. In addition, the rising demand for pet insurance, strategic initiatives undertaken by key participants, and government initiatives are likely to boost industry growth.Various government policies are affecting the veterinary active pharmaceutical ingredients (API) manufacturing.
For instance, in India, despite a strong base, domestic veterinary pharmaceutical companies have gradually stopped manufacturing veterinary APIs due to low-profit margins. They started importing APIs from other countries, a majority of which are imported from China, which was a cheaper alternative and increased their profit margin on drugs. The Technology Information Forecasting and Assessment Council-an organization under the Department of Science & Technology, India-recommended a few guidelines to address the need for regulating APIs to make India self-reliant and revive its economy post-pandemic. This is important to reduce India’s dependency on China for pharmaceutical goods, including APIs, especially after the tensions between soldiers at the India–China border.
Various guidelines are being issued by government organizations to encourage veterinary services globally, which is anticipated to aid veterinary API manufacturing market growth in the coming years. An increase in the number of government initiatives that help promote animal health is also expected to fuel the overall market growth during the forecast period. The launch of One Health Initiative for enhancing animal healthcare standards has improved growth prospects for the industry. This joint project unified clinical care, disease surveillance, and education & research areas for better control of diseases. The growing need for efficient animal treatment and increasing awareness about pathogenesis & epidemiology have encouraged organizations, such as Companion Animal Adoption Resources and the Federation of European Companion Animal Veterinary Association, to take appropriate measures.
Government and private organizations are constantly updating their guidelines to promote animal health and prevent obesity & other disorders. This is expected to fuel industry growth over the forecast period.The increasing number of oral formulations for various veterinary drugs is boosting the demand for veterinary APIs. These majorly include nonsteroidal anti-inflammatory drugs. Manufacturers are investing in electrochemical synthesis, which helps in accelerating the manufacturing process for APIs. In addition, the introduction of biologically synthesized APIs is a technological innovation that fuels industry growth. Going forward, veterinary biopharmaceuticals produced by rDNA technology will be gaining more significance, as they would be a better choice for managing diseases, such as arthritis, cancer, & diabetes, and autoimmune disorders.
Furthermore, the introduction of High-Potency APIs (HPAPIs), which act on the target cells in a much lower dose as compared to the general APIs, is also expected to offer lucrative growth opportunities in the vet API Manufacturing market. The HPAPIs are creating significant changes in pharmaceutical innovation to deliver new therapeutic medicines.Some of the macroeconomic factors, such as COVID-19, have widely impacted veterinary consumer demand, as human medicines, including antivirals, were in high requirement during the pandemic. According to SeQuent Scientific Ltd., 2021, rising geopolitical tensions amid the Ukraine-Russia conflicts are also expected to create uncertainty in the supply chain, financial stress, & climate-related changes, as well as increase inflation in the near term.
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights
- Some API manufacturing companies have been gaining traction since the COVID-19 pandemic
- For instance, the share of companies, such as Lasa Supergenerics-a company involved in veterinary and human APIs-increased to 108% by February 2020 compared to February 2019 owing to the exponential rise in the demand for human APIs by drug manufacturers
- The contract outsourcing segment accounted for the highest revenue share in 2022 owing to its associated benefits. Earlier, veterinary pharma drug manufacturers would opt for an in-house model and prepare their APIs
- The chemical-based API segment is expected to drive industry growth over the forecast period owing to its high usage among veterinary pharmaceutical companies
- The anti-infectives segment dominated the industry in 2022. Growing challenges among livestock owners to uphold veterinary health standards to meet the demand for healthy dairy products, fresh meat, and dietary nutrition are driving the need for anti-infective drug production
- North America is expected to dominate the industry over the forecast perioddue to the high prevalence of zoonotic diseases across the region
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources & Third-Party Perspectives
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information/Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 Market Definitions
1.8 List Of Secondary Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot, 2022
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
CHAPTER 3 VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURING MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration And Growth Prospect Mapping, By Synthesis Type, 2022
3.3 Veterinary Api Manufacturing Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increasing Prevalence Of Zoonotic Diseases
3.3.1.2 Increasing Animal Population And Pet Ownership
3.3.1.3 Growing Pet Expenditure
3.3.1.4 Rising Number Of Veterinarians And Veterinary Visits
3.3.1.5 Growing Demand For Pet Insurance
3.3.1.6 Strategic Initiatives Undertaken By Market Players
3.3.1.7 Growing Government Initiatives
3.3.2 Market Restraint Analysis
3.3.2.1 Stringent Government Regulations
3.3.2.2 Lack Of Awareness And High Cost Of Animal Care
3.3.3 Market Challenges Analysis
3.3.3.1 Illegal Veterinary Medicines
3.3.3.2 Challenges In Large Molecule Api Synthesis
3.4 Veterinary Active Pharmaceutical Ingredients (Api) Manufacturing Market Analysis Tools: Porters
3.4.1 Bargaining Power Of Suppliers: Low
3.4.2 Bargaining Power Of Buyers: Moderate
3.4.3 Threat Of Substitutes: Moderate
3.4.4 Threat Of New Entrants: Moderate
3.4.5 Competitive Rivalry: High
3.5 Veterinary Active Pharmaceutical Ingredients (Api) Manufacturing Market Analysis Tools: Pest Analysis
3.5.1 Political & Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape
3.6 Regulatory Landscape
3.6.1 North America
3.6.2 Europe
3.6.3 Asia-Pacific
3.6.4 Latin America
3.6.5 MEA
3.7 Pricing Analysis
3.8 Forecast Analysis
3.8.1 Technology & Trends In Api Manufacturing
CHAPTER 4 SERVICE TYPE ESTIMATES & TREND ANALYSIS, 2018 - 2030 (USD MILLION)
4.1 Service Type Movement Analysis, 2018 - 2030 (USD Million)
4.2 Veterinary Active Pharmaceutical Ingredients (API) Manufacturing Market Share Analysis, 2022 & 2030
4.3 In-House
4.3.1 In-House Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4 Contract Outsourcing
4.4.1 Contract Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.2 Contract Development
4.4.2.1 Contract Development Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.2.2 Preclinical Development
4.4.2.2.1 Preclinical Development Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.2.3 Others
4.4.2.3.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.3 Contract Manufacturing
4.4.3.1 Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.3.2 Api/Bulk Drugs
4.4.3.2.1 Api/Bulk Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.3.3 Finished Dose Formulations
4.4.3.3.1 Finished Dose Formulations Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5 SYNTHESIS TYPE ESTIMATES & TREND ANALYSIS, 2018 - 2030 (USD MILLION)
5.1 Synthesis Type Movement Analysis, 2018 - 2030 (USD Million)
5.2 Veterinary Active Pharmaceutical Ingredients (API) Manufacturing Market Share Analysis, 2022 & 2030
5.3 Chemical-Based Api
5.3.1 Chemical-Based Active Pharmaceutical Ingredients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.4 Biological Api
5.4.1 Biological Active Pharmaceutical Ingredients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5 Hpapi
5.5.1 Hpapi Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6 THERAPEUTIC CATEGORY ESTIMATES & TREND ANALYSIS, 2018 - 2030 (USD MILLION)
6.1 Therapeutic Category Movement Analysis, 2018 - 2030 (USD Million)
6.2 Veterinary Active Pharmaceutical Ingredients (Api) Manufacturing Market Share Analysis, 2022 & 2030
6.3 Antiparasitic
6.3.1 Antiparasitic Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4 Anti-Infectives
6.4.1 Anti-Infectives Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5 Nsaids
6.5.1 Nsaids Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6 Others
6.6.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7 ANIMAL TYPE ESTIMATES & TREND ANALYSIS, 2018 - 2030 (USD MILLION)
7.1 Animal Type Movement Analysis, 2018 - 2030 (USD Million)
7.2 Veterinary Active Pharmaceutical Ingredients (Api) Manufacturing Market Share Analysis, 2022 & 2030
7.3 Companion Animals
7.3.1 Companion Animals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4 Production/Food Animals
7.4.1 Production/Food Animals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8 REGIONAL ESTIMATES & TREND ANALYSIS, 2018 - 2030 (USD MILLION)
8.1 Regional Market Snapshot
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 North America
8.3.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4 Europe
8.4.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2 U.K.
8.4.2.1 U.K. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3 Germany
8.4.3.1 Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4 France
8.4.4.1 France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.5 Italy
8.4.5.1 Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.6 Spain
8.4.6.1 Spain Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5 Asia Pacific
8.5.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2 China
8.5.2.1 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3 Japan
8.5.3.1 Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4 India
8.5.4.1 India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6 Latam
8.6.1 Latam Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.2 Brazil
8.6.2.1 Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3 Mexico
8.6.3.1 Mexico Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7 MEA
8.7.1 Mea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.2 South Africa
8.7.2.1 South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.3 Saudi Arabia
8.7.3.1 Saudi Arabia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Company Market Position Analysis
9.2 Synergy Analysis: Major Deals & Strategic Alliances
CHAPTER 10 VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURING MARKET – COMPANY PROFILES
10.1 Alivira Animal Health Limited
10.1.1 Company Overview
10.1.2 Financial Performance
10.1.3 Product Benchmarking
10.1.4 Strategic Initiatives
10.2 Excel Industries Ltd.
10.2.1 Company Overview
10.2.2 Financial Performance
10.2.3 Product Benchmarking
10.3 Ofichem Group
10.3.1 Company Overview
10.3.2 Product Benchmarking
10.3.3 Strategic Initiatives
10.4 Chempro Pharma Private Limited
10.4.1 Company Overview
10.4.2 Product Benchmarking
10.5 Menadiona
10.5.1 Company Overview
10.5.2 Financial Performance
10.5.3 Product Benchmarking
10.5.4 Strategic Initiatives
10.6 SUANFARMA
10.6.1 Company Overview
10.6.2 Financial Performance
10.6.3 Product Benchmarking
10.6.4 STRATEGIC INITIATIVES
10.7 Vetpharma (Insud Pharma, S.L.U)
10.7.1 Company Overview
10.7.2 Product Benchmarking
10.7.3 Strategic Initiatives
10.8 Siflon Drugs
10.8.1 Company Overview
10.8.2 Product Benchmarking
10.9 Qilu Pharmaceuticals Co. Ltd.
10.9.1 Company Overview
10.9.2 Financial Performance
10.9.3 Product Benchmarking
10.10 FIS - Fabbrica Italiana Sintetici S.p.A.
10.10.1 Company Overview
10.10.2 Product Benchmarking
10.10.3 Strategic Initiatives
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources & Third-Party Perspectives
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information/Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 Market Definitions
1.8 List Of Secondary Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot, 2022
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
CHAPTER 3 VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURING MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration And Growth Prospect Mapping, By Synthesis Type, 2022
3.3 Veterinary Api Manufacturing Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increasing Prevalence Of Zoonotic Diseases
3.3.1.2 Increasing Animal Population And Pet Ownership
3.3.1.3 Growing Pet Expenditure
3.3.1.4 Rising Number Of Veterinarians And Veterinary Visits
3.3.1.5 Growing Demand For Pet Insurance
3.3.1.6 Strategic Initiatives Undertaken By Market Players
3.3.1.7 Growing Government Initiatives
3.3.2 Market Restraint Analysis
3.3.2.1 Stringent Government Regulations
3.3.2.2 Lack Of Awareness And High Cost Of Animal Care
3.3.3 Market Challenges Analysis
3.3.3.1 Illegal Veterinary Medicines
3.3.3.2 Challenges In Large Molecule Api Synthesis
3.4 Veterinary Active Pharmaceutical Ingredients (Api) Manufacturing Market Analysis Tools: Porters
3.4.1 Bargaining Power Of Suppliers: Low
3.4.2 Bargaining Power Of Buyers: Moderate
3.4.3 Threat Of Substitutes: Moderate
3.4.4 Threat Of New Entrants: Moderate
3.4.5 Competitive Rivalry: High
3.5 Veterinary Active Pharmaceutical Ingredients (Api) Manufacturing Market Analysis Tools: Pest Analysis
3.5.1 Political & Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape
3.6 Regulatory Landscape
3.6.1 North America
3.6.2 Europe
3.6.3 Asia-Pacific
3.6.4 Latin America
3.6.5 MEA
3.7 Pricing Analysis
3.8 Forecast Analysis
3.8.1 Technology & Trends In Api Manufacturing
CHAPTER 4 SERVICE TYPE ESTIMATES & TREND ANALYSIS, 2018 - 2030 (USD MILLION)
4.1 Service Type Movement Analysis, 2018 - 2030 (USD Million)
4.2 Veterinary Active Pharmaceutical Ingredients (API) Manufacturing Market Share Analysis, 2022 & 2030
4.3 In-House
4.3.1 In-House Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4 Contract Outsourcing
4.4.1 Contract Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.2 Contract Development
4.4.2.1 Contract Development Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.2.2 Preclinical Development
4.4.2.2.1 Preclinical Development Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.2.3 Others
4.4.2.3.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.3 Contract Manufacturing
4.4.3.1 Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.3.2 Api/Bulk Drugs
4.4.3.2.1 Api/Bulk Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.3.3 Finished Dose Formulations
4.4.3.3.1 Finished Dose Formulations Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5 SYNTHESIS TYPE ESTIMATES & TREND ANALYSIS, 2018 - 2030 (USD MILLION)
5.1 Synthesis Type Movement Analysis, 2018 - 2030 (USD Million)
5.2 Veterinary Active Pharmaceutical Ingredients (API) Manufacturing Market Share Analysis, 2022 & 2030
5.3 Chemical-Based Api
5.3.1 Chemical-Based Active Pharmaceutical Ingredients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.4 Biological Api
5.4.1 Biological Active Pharmaceutical Ingredients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5 Hpapi
5.5.1 Hpapi Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6 THERAPEUTIC CATEGORY ESTIMATES & TREND ANALYSIS, 2018 - 2030 (USD MILLION)
6.1 Therapeutic Category Movement Analysis, 2018 - 2030 (USD Million)
6.2 Veterinary Active Pharmaceutical Ingredients (Api) Manufacturing Market Share Analysis, 2022 & 2030
6.3 Antiparasitic
6.3.1 Antiparasitic Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4 Anti-Infectives
6.4.1 Anti-Infectives Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5 Nsaids
6.5.1 Nsaids Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6 Others
6.6.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7 ANIMAL TYPE ESTIMATES & TREND ANALYSIS, 2018 - 2030 (USD MILLION)
7.1 Animal Type Movement Analysis, 2018 - 2030 (USD Million)
7.2 Veterinary Active Pharmaceutical Ingredients (Api) Manufacturing Market Share Analysis, 2022 & 2030
7.3 Companion Animals
7.3.1 Companion Animals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4 Production/Food Animals
7.4.1 Production/Food Animals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8 REGIONAL ESTIMATES & TREND ANALYSIS, 2018 - 2030 (USD MILLION)
8.1 Regional Market Snapshot
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 North America
8.3.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4 Europe
8.4.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2 U.K.
8.4.2.1 U.K. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3 Germany
8.4.3.1 Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4 France
8.4.4.1 France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.5 Italy
8.4.5.1 Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.6 Spain
8.4.6.1 Spain Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5 Asia Pacific
8.5.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2 China
8.5.2.1 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3 Japan
8.5.3.1 Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4 India
8.5.4.1 India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6 Latam
8.6.1 Latam Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.2 Brazil
8.6.2.1 Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3 Mexico
8.6.3.1 Mexico Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7 MEA
8.7.1 Mea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.2 South Africa
8.7.2.1 South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.3 Saudi Arabia
8.7.3.1 Saudi Arabia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Company Market Position Analysis
9.2 Synergy Analysis: Major Deals & Strategic Alliances
CHAPTER 10 VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURING MARKET – COMPANY PROFILES
10.1 Alivira Animal Health Limited
10.1.1 Company Overview
10.1.2 Financial Performance
10.1.3 Product Benchmarking
10.1.4 Strategic Initiatives
10.2 Excel Industries Ltd.
10.2.1 Company Overview
10.2.2 Financial Performance
10.2.3 Product Benchmarking
10.3 Ofichem Group
10.3.1 Company Overview
10.3.2 Product Benchmarking
10.3.3 Strategic Initiatives
10.4 Chempro Pharma Private Limited
10.4.1 Company Overview
10.4.2 Product Benchmarking
10.5 Menadiona
10.5.1 Company Overview
10.5.2 Financial Performance
10.5.3 Product Benchmarking
10.5.4 Strategic Initiatives
10.6 SUANFARMA
10.6.1 Company Overview
10.6.2 Financial Performance
10.6.3 Product Benchmarking
10.6.4 STRATEGIC INITIATIVES
10.7 Vetpharma (Insud Pharma, S.L.U)
10.7.1 Company Overview
10.7.2 Product Benchmarking
10.7.3 Strategic Initiatives
10.8 Siflon Drugs
10.8.1 Company Overview
10.8.2 Product Benchmarking
10.9 Qilu Pharmaceuticals Co. Ltd.
10.9.1 Company Overview
10.9.2 Financial Performance
10.9.3 Product Benchmarking
10.10 FIS - Fabbrica Italiana Sintetici S.p.A.
10.10.1 Company Overview
10.10.2 Product Benchmarking
10.10.3 Strategic Initiatives
LIST OF TABLES
Table 1. List of secondary sources
Table 2. List of key API manufacturers
Table 3. North America veterinary active pharmaceutical ingredients (API) manufacturing market, by country, 2018 - 2030 (USD Million)
Table 4. North America veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 5. North America veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 6. North America veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 7. North America veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 8. U.S. veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 9. U.S. veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 10. U.S. veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 11. U.S. veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 12. Canada veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 13. Canada veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 14. Canada veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 15. Canada veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 16. Europe veterinary active pharmaceutical ingredients (API) manufacturing market, by country, 2018 - 2030 (USD Million)
Table 17. Europe veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 18. Europe veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 19. Europe veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 20. Europe veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 21. U.K. veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 22. U.K. veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 23. U.K. veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 24. U.K. veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 25. Germany veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 26. Germany veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 27. Germany veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 28. Germany veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 29. France veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 30. France veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 31. France veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 32. France veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 33. Italy veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 34. Italy veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 35. Italy veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 36. Italy veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 37. Spain veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 38. Spain veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 39. Spain veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 40. Spain veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 41. Asia pacific veterinary active pharmaceutical ingredients (API) manufacturing market, by country, 2018 - 2030 (USD Million)
Table 42. Asia pacific veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 43. Asia pacific veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 44. Asia Pacific veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 45. Asia Pacific veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 46. China veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 47. China veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 48. China veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 49. China veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 50. Japan veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 51. Japan veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 52. Japan veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 53. Japan veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 54. India veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 55. India veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 56. India veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 57. India veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 58. LATAM veterinary active pharmaceutical ingredients (API) manufacturing market, by country, 2018 - 2030 (USD Million)
Table 59. LATAM veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 60. LATAM veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 61. LATAM veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 62. LATAM veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 63. Brazil veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 64. Brazil veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 65. Brazil veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 66. Brazil veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 67. Mexico veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 68. Mexico veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 69. Mexico veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 70. Mexico veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 71. MEA veterinary active pharmaceutical ingredients (API) manufacturing market, by country, 2018 - 2030 (USD Million)
Table 72. MEA veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 73. MEA veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 74. MEA veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 75. MEA veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 76. South Africa veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 77. South Africa veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 78. South Africa veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 79. South Africa veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 80. Saudi Arabia veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 81. Saudi Arabia veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 82. Saudi Arabia veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 83. Saudi Arabia veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 84. Global veterinary active pharmaceutical ingredients (API) manufacturing market, by region, 2018 - 2030 (USD Million)
Table 85. Global veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 86. Global veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 87. Global veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 88. Global veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 1. List of secondary sources
Table 2. List of key API manufacturers
Table 3. North America veterinary active pharmaceutical ingredients (API) manufacturing market, by country, 2018 - 2030 (USD Million)
Table 4. North America veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 5. North America veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 6. North America veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 7. North America veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 8. U.S. veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 9. U.S. veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 10. U.S. veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 11. U.S. veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 12. Canada veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 13. Canada veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 14. Canada veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 15. Canada veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 16. Europe veterinary active pharmaceutical ingredients (API) manufacturing market, by country, 2018 - 2030 (USD Million)
Table 17. Europe veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 18. Europe veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 19. Europe veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 20. Europe veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 21. U.K. veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 22. U.K. veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 23. U.K. veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 24. U.K. veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 25. Germany veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 26. Germany veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 27. Germany veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 28. Germany veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 29. France veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 30. France veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 31. France veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 32. France veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 33. Italy veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 34. Italy veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 35. Italy veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 36. Italy veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 37. Spain veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 38. Spain veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 39. Spain veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 40. Spain veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 41. Asia pacific veterinary active pharmaceutical ingredients (API) manufacturing market, by country, 2018 - 2030 (USD Million)
Table 42. Asia pacific veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 43. Asia pacific veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 44. Asia Pacific veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 45. Asia Pacific veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 46. China veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 47. China veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 48. China veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 49. China veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 50. Japan veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 51. Japan veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 52. Japan veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 53. Japan veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 54. India veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 55. India veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 56. India veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 57. India veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 58. LATAM veterinary active pharmaceutical ingredients (API) manufacturing market, by country, 2018 - 2030 (USD Million)
Table 59. LATAM veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 60. LATAM veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 61. LATAM veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 62. LATAM veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 63. Brazil veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 64. Brazil veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 65. Brazil veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 66. Brazil veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 67. Mexico veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 68. Mexico veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 69. Mexico veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 70. Mexico veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 71. MEA veterinary active pharmaceutical ingredients (API) manufacturing market, by country, 2018 - 2030 (USD Million)
Table 72. MEA veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 73. MEA veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 74. MEA veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 75. MEA veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 76. South Africa veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 77. South Africa veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 78. South Africa veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 79. South Africa veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 80. Saudi Arabia veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 81. Saudi Arabia veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 82. Saudi Arabia veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 83. Saudi Arabia veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
Table 84. Global veterinary active pharmaceutical ingredients (API) manufacturing market, by region, 2018 - 2030 (USD Million)
Table 85. Global veterinary active pharmaceutical ingredients (API) manufacturing market, by service type, 2018 - 2030 (USD Million)
Table 86. Global veterinary active pharmaceutical ingredients (API) manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
Table 87. Global veterinary active pharmaceutical ingredients (API) manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
Table 88. Global veterinary active pharmaceutical ingredients (API) manufacturing market, by animal type, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Veterinary Active Pharmaceutical Ingredients (API) Manufacturing Market Segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 General methodology for commodity flow analysis of animal health market
Fig. 9 Commodity flow analysis
Fig. 10 Parent market analysis
Fig. 11 Global animal vaccines market, 2018 - 2030 (USD Million)
Fig. 12 Global animal biologics market, 2018 - 2030 (USD Million)
Fig. 13 Market snapshot
Fig. 14 Segment snapshot
Fig. 15 Segment snapshot
Fig. 16 Competitive landscape snapshot
Fig. 17 Parent market outlook
Fig. 18 Ancillary market outlook
Fig. 19 Penetration & growth prospect mapping, by synthesis type, 2022
Fig. 20 Veterinary API manufacturing market dynamics
Fig. 21 Veterinary API manufacturing market driver impact
Fig. 22 Pet ownership by generation, 2021 - 2022 (% share)
Fig. 23 Total pet expenditure in the U.S., 2018 - 2021 (USD Billion)
Fig. 24 Veterinary API manufacturing market restraint impact
Fig. 25 Flow diagram of API process
Fig. 26 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market: Service type movement analysis, 2018 - 2030 (USD Million)
Fig. 27 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market share analysis, 2022 & 2030
Fig. 28 In-house market, 2018 - 2030 (USD Million)
Fig. 29 Contract outsourcing market, 2018 - 2030 (USD Million)
Fig. 30 Contract development market, 2018 - 2030 (USD Million)
Fig. 31 Preclinical development market, 2018 - 2030 (USD Million)
Fig. 32 Others market, 2018 - 2030 (USD Million)
Fig. 33 Contract manufacturing market, 2018 - 2030 (USD Million)
Fig. 34 API/Bulk drugs market, 2018 - 2030 (USD Million)
Fig. 35 Finished dose formulations market, 2018 - 2030 (USD Million)
Fig. 36 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market: Synthesis type movement analysis, 2018 - 2030 (USD Million)
Fig. 37 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market share analysis, 2022 & 2030
Fig. 38 Chemical-based API market, 2018 - 2030 (USD Million)
Fig. 39 Biological API market, 2018 - 2030 (USD Million)
Fig. 40 HPAPI market, 2018 - 2030 (USD Million)
Fig. 41 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market: Therapeutic category movement analysis, 2018 - 2030 (USD Million)
Fig. 42 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market share analysis, 2022 & 2030
Fig. 43 Antiparasitic market, 2018 - 2030 (USD Million)
Fig. 44 Anti-infectives market, 2018 - 2030 (USD Million)
Fig. 45 NSAIDs market, 2018 - 2030 (USD Million)
Fig. 46 Others market, 2018 - 2030 (USD Million)
Fig. 47 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market: Animal type movement analysis, 2018 - 2030 (USD Million)
Fig. 48 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market share analysis, 2022 & 2030
Fig. 49 Companion animals market, 2018 - 2030 (USD Million)
Fig. 50 Production/food animals market, 2018 - 2030 (USD Million)
Fig. 51 Regional market snapshot
Fig. 52 Regional market share analysis, 2022 & 2030
Fig. 53 North America veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 54 U.S. Veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 55 Canada veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 56 Europe veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 57 U.K. veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 58 Germany veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 59 France veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 60 Italy veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 61 Spain veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 62 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 63 China veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 64 Japan veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 65 India veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 66 LATAM veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 67 Brazil veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 68 Mexico veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 69 MEA veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 70 South Africa veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 71 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 72 Public company market position analysis
Fig. 73 Major deals & strategic alliances analysis
Fig. 1 Veterinary Active Pharmaceutical Ingredients (API) Manufacturing Market Segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 General methodology for commodity flow analysis of animal health market
Fig. 9 Commodity flow analysis
Fig. 10 Parent market analysis
Fig. 11 Global animal vaccines market, 2018 - 2030 (USD Million)
Fig. 12 Global animal biologics market, 2018 - 2030 (USD Million)
Fig. 13 Market snapshot
Fig. 14 Segment snapshot
Fig. 15 Segment snapshot
Fig. 16 Competitive landscape snapshot
Fig. 17 Parent market outlook
Fig. 18 Ancillary market outlook
Fig. 19 Penetration & growth prospect mapping, by synthesis type, 2022
Fig. 20 Veterinary API manufacturing market dynamics
Fig. 21 Veterinary API manufacturing market driver impact
Fig. 22 Pet ownership by generation, 2021 - 2022 (% share)
Fig. 23 Total pet expenditure in the U.S., 2018 - 2021 (USD Billion)
Fig. 24 Veterinary API manufacturing market restraint impact
Fig. 25 Flow diagram of API process
Fig. 26 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market: Service type movement analysis, 2018 - 2030 (USD Million)
Fig. 27 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market share analysis, 2022 & 2030
Fig. 28 In-house market, 2018 - 2030 (USD Million)
Fig. 29 Contract outsourcing market, 2018 - 2030 (USD Million)
Fig. 30 Contract development market, 2018 - 2030 (USD Million)
Fig. 31 Preclinical development market, 2018 - 2030 (USD Million)
Fig. 32 Others market, 2018 - 2030 (USD Million)
Fig. 33 Contract manufacturing market, 2018 - 2030 (USD Million)
Fig. 34 API/Bulk drugs market, 2018 - 2030 (USD Million)
Fig. 35 Finished dose formulations market, 2018 - 2030 (USD Million)
Fig. 36 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market: Synthesis type movement analysis, 2018 - 2030 (USD Million)
Fig. 37 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market share analysis, 2022 & 2030
Fig. 38 Chemical-based API market, 2018 - 2030 (USD Million)
Fig. 39 Biological API market, 2018 - 2030 (USD Million)
Fig. 40 HPAPI market, 2018 - 2030 (USD Million)
Fig. 41 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market: Therapeutic category movement analysis, 2018 - 2030 (USD Million)
Fig. 42 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market share analysis, 2022 & 2030
Fig. 43 Antiparasitic market, 2018 - 2030 (USD Million)
Fig. 44 Anti-infectives market, 2018 - 2030 (USD Million)
Fig. 45 NSAIDs market, 2018 - 2030 (USD Million)
Fig. 46 Others market, 2018 - 2030 (USD Million)
Fig. 47 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market: Animal type movement analysis, 2018 - 2030 (USD Million)
Fig. 48 Veterinary Active Pharmaceutical Ingredients (API) manufacturing market share analysis, 2022 & 2030
Fig. 49 Companion animals market, 2018 - 2030 (USD Million)
Fig. 50 Production/food animals market, 2018 - 2030 (USD Million)
Fig. 51 Regional market snapshot
Fig. 52 Regional market share analysis, 2022 & 2030
Fig. 53 North America veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 54 U.S. Veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 55 Canada veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 56 Europe veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 57 U.K. veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 58 Germany veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 59 France veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 60 Italy veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 61 Spain veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 62 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 63 China veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 64 Japan veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 65 India veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 66 LATAM veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 67 Brazil veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 68 Mexico veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 69 MEA veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 70 South Africa veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 71 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
Fig. 72 Public company market position analysis
Fig. 73 Major deals & strategic alliances analysis
